- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Morepen Laboratories Limited has approved the hiving off of its Medical Devices Business to its subsidiary, Morepen Medtech Limited, on a slump sale basis. This strategic move aims to enhance focus on the medical devices sector and provide operational independence. For the financial year ending March 31, 2024, the Medical Devices Business accounted for a turnover of ₹442.72 crore, representing 26.19% of the company's total revenue, alongside a net worth of ₹90.79 crore. The completion of the sale is anticipated by September 30, 2025, pending necessary regulatory and member approvals, with consideration based on an independent valuation of relevant assets. As this transaction qualifies as a related party transaction, it will be executed on an arm's length basis, assuring compliance and transparency. Investors should watch closely for developments regarding this transition, as it may signal a positive outlook for the company's strategic positioning in the medical devices market.